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33635
Recalcitrant bullous rash presenting in a pediatric patient, ultimately responsive to dupilimab
Kimberly Shao, MD, University of Connecticut, Department of
Dermatology; Katalin Ferenczi, MD
A 17-year-old female reported a pruritic blister on the left breast 2 months prior to
presentation. Within a month she noticed vesicles on the inner legs. Her primary
care physician prescribed doxycycline for possible impetigo. The lesions continued
to spread so she was referred to dermatology. On examination, there were multiple
tense bullae symmetrically distributed on the face, trunk, and extremities. There was
a single erosion of the hard palate and excoriated vesicles of the labia majora. A
biopsy showed a subepidermal split with a predominance of neutrophils and
eosinophils. Direct immunofluorescence revealed continuous, linear, homogenous
C3 and IgG deposition along the dermoepidermal junction. Indirect immunofluorescence demonstrated positive IgG basement membrane zone antibody reactivity
on monkey esophagus with epidermal localization on salt-split. IgG type VII collagen
antibody level was normal by ELISA. BP 180 antibodies were elevated (574 units).
She was ultimately diagnosed with childhood bullous pemphigoid. Quantitative
hCG was negative. Intravenous methylprednisolone initially improved pruritus and
pain, but transition to oral prednisone plus dapsone failed to control symptoms, so
rituximab was started. As her condition acutely worsened, we elected for a course of
plasmapheresis. While there was significant improvement in her symptoms, the
patient continued to report new vesicles. Plasmapheresis was discontinued and
IVIG was added. Though her BP antigens downtrended, new lesion formation
persisted. Mycophenolate mofetil was poorly tolerated. Dupilimab was started at
300 mg every other week. Over 4 months, the patient’s BP antigens normalized, she
denied new lesions, and we able to discontinue rituximab and IVIG.
Commercial Disclosure: None identified.
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Reddit and dermatology: Analyzing user-submitted posts seeking
dermatologic
advice
on
r/SkincareAddiction
and
r/DermatologyQuestions
Kevin Lee, BS, University of Texas at Houston McGovern Medical
School, Houston, TX; Nader Aboul-Fettouh, MD, Department of Dermatology,
The University of Texas Health Science Center at Houston, Houston, TX; Natalie
Kash, MD, Department of Dermatology, Kansas City University-Graduate Medical
Education Consortium/Advanced Dermatology and Cosmetic Surgery Orlando
Dermatology Program, Maitland, FL
Reddit, a popular social media website, has numerous forums where users may
discuss health care related topics and request diagnostic advice for dermatologic
conditions. In 2020, Reddit had accumulated 42 million daily active users, 303.4
million posts, 2 billion comments, and 49.2 billion ‘upvotes’ e an action that
increases the visibility of the posts to other reddit users. Our study was conducted to
analyze the top responses of 300 user-submitted requests for dermatologic advice on
2 popular reddit forums (150 posts each from SkinCareAddiction and
DermatologyQuestions). Posts were only included if a photograph was also
submitted. Three board-certified dermatologists reviewed each post, providing a
diagnosis, followed by grading the post’s top user-submitted comment for specific
criteria including accuracy, appropriateness, and whether the comments were
misleading or potentially dangerous. Grading was performed using a 5-point scale
where 5 correlated to the highest level of accuracy and appropriateness. Mean
scores for the top comment’s accuracy and appropriateness were 3.28 (95% CI 3.123.45) and 3.3 (95% CI 3.14-3.45), respectively. On a 5-point scale where 5 correlated
with a comment that was highly misleading/potentially dangerous, the average
reddit comment grade was 2.33 (95% CI 2.18-2.48). Social media sites, such as
Reddit, may be beneficial to patients requesting dermatologic advice. However,
responses should be taken with caution as the information provided may be
inaccurate or insufficient for treatment recommendations. Dermatologists should be
aware of these freely available online resources which patients use to seek
dermatologic diagnoses and treatment advice.
Commercial Disclosure: None identified.
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Recalcitrant pediatric bullous erythema multiforme responsive
to oral tofacitinib
Sasank Konda, MD, Henry Ford Health System; Nayha Shetty, MD,
Henry Ford Health System; Jesse Liu, MD, Henry Ford Health System
Patient history and physical: A 25-year-old African American female was admitted for
painful oral erosions and widespread blistering lesions on the trunk and extremities
which had been waxing and waning since age 12 years old. Disease flares requiring
hospitalization had been continuing to occur multiple times annually in spite of
numerous systemic immunosuppressive agents including chronic corticosteroids
(resulting in Cushingoid features and insulin-dependent diabetes) in combination
with cyclosporine, dapsone, tacrolimus, anakinra, rituximab, adalimumab, apremilast, mycophenolate mofetil, and intravenous immunoglobulin (IVIG) at various
times. Adjunctive therapies including acyclovir and leuprolide had also proven
ineffective. Physical examination revealed well-defined, targetoid macules with
central vesiculation scattered upon all four extremities. Ill-defined, annular-appearing, hyperpigmented macules were observed on the trunk. Scattered, erythematous
erosions were seen on the hard palate and buccal mucosa; in addition, the lips
featured hemorrhagic crusts. Biopsies: Punch biopsies of lesions obtained from the
left arm revealed a brisk lymphocytic infiltrate at the dermoepidermal junction with
necrotic keratinocytes observed at all levels of the epidermis. Laboratory Data:
Further work-up revealed negative PCR for EBV & CMV, negative ANA, negative HIV,
negative Mycoplasma antibodies, and negative HSV-2 & HSV-2 antibodies. Diagnosis:
Bullous erythema multiforme. Clinical Course and Treatment: Patient was transitioned to oral tofacitinib 5 mg twice daily with corresponding complete resolution
of active lesions. Disease activity has remained quiescent for over two years, which
represents the longest period of time without a disease flare since the patient’s
initial diagnosis during childhood.
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Refractory pustular psoriasis treated successfully with IL-23
inhibitors. Report of 1 patient with generalized pustular psoriasis
and 4 patients with palmoplantar pustulosis
Maria Politou, MD, 1st University Clinic Dermatology-Venereology
‘‘A.Syggros ‘‘ Hospital, National and Kapodistrian UOA, Greece; Kleidona Ileana
Afroditi, MD, MSc, 1st University Clinic Dermatology-Venereology ‘‘A.Syggros ‘‘
Hospital, National and Kapodistrian UOA, Greece; Nikolaidou Electra, Professor,
1st University Clinic Dermatology-Venereology ‘‘A.Syggros ‘‘ Hospital, National
and Kapodistrian UOA, Greece
Introduction: It is known that the key inflammatory cytokines in plaque psoriasis are
TNF-a/IL-23/IL-17/IL-22. Conversely, recent data demonstrate that pustular psoriasis
is mainly characterized by a neutrophil-driven inflammatory response following
‘‘hyperactivation’’ of the IL-36 axis. However, it appears that these 2 pathways crosstalk to each other and act synergistically in the pathophysiologic mechanism of
pustule formation. In terms of guidance to treatment, no robust data exist.
Considering the advances into the pathophysiology, arises the question whether
the novel IL-23 antagonists could lead to clinical improvement.
Methods: We present a 75-year-old female patient with generalized-pustular-psoriasis for 10 years and 4 patients (2 females and 2 males) 53, 58, 60, and 62 years old
with palmoplantar-pustulosis for 3, 5, 5, and 6 years, respectively. The former had
unsuccessfully undergone every available at that point systemic therapy (both
conventional and biologic) whereas the laters had failed acitretin, MTX/acitretin,
apremilast/acitretin, acitretin/MTX/apremilast respectively. All five had PGA score
[3. We initiated an IL-23 inhibitor. Patient with the generalized-pustular form and 2
patients with the palmoplantar form received risankizumab whereas the other 2
guselkumab.
Results: All 4 had reached PPPGA 0/1 by week 12, whereas the patient with
generalized pustular form had reached PGA 1 by week 16. Formers are currently
undergoing the sixth month of therapy, whereas the later the eighteenth month and
still present great response.
Conclusions: Il-23 might be a key operator in the interconnection of the complex
pathogenetic pathways in pustular psoriasis. Therefore, IL-23 inhibition could be a
therapeutic option. More data are required.
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